Center-Authored Papers

Filters: Author is Kumar, Shaji  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Cornell RF, D'Souza A, Kassim AA, Costa LJ, Innis-Shelton RD, Zhang M-J, Huang J, Abidi M, Aiello J, Akpek G et al..  2016.  Maintenance Versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
K
Kumar S, Giralt S, Stadtmauer EA, Harousseau JL, Palumbo A, Bensinger WI, Comenzo RL, Lentzsch S, Munshi N, Niesvizky R et al..  2009.  Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens.. Blood. 114(9):1729-35. Abstract
M
Mahindra A, Raval G, Mehta P, Brazauskas R, Zhang M-J, Zhong X, Bird JM, Freytes CO, Hale GA, Herzig R et al..  2015.  New cancers after autotransplantations for multiple myeloma.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(4):738-45. Abstract
Michaelis LC, Saad A, Zhong X, Le-Rademacher J, Freytes CO, Marks DI, Lazarus HM, Bird JM, Holmberg L, Kamble RT et al..  2013.  Salvage Second Hematopoietic Cell Transplantation in Myeloma.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
S
Scott EC, Hari P, Sharma M, Le-Rademacher J, Huang J, Vogl D, Abidi M, Beitinjaneh A, Fung H, Ganguly S et al..  2016.  Post-Transplant Outcomes in High-Risk Compared with Non-High-Risk Multiple Myeloma: A CIBMTR Analysis.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 22(10):1893-1899. Abstract